Latest News

Vanizem nominated for the Vitafoods EU awards 2025
We’re happy to announce that Vanizem® has been nominated for the Vitafoods Europe Innovation Awards 2025!

Efficacité de Sulfodyne® pour la prise en charge du syndrome prémenstruel : une nouvelle étude en situation réelle
Une étude en conditions de vie réelles sur 50 femmes confirme l'efficacité de SULFODYNE®, l’unique et authentique extrait de sulforaphane naturel et actif pour la gestion du syndrome prémenstruel.

Effectiveness of Sulfodyne® for the management of premenstrual syndrome: a new real-life study
A real-life study on 50 women confirms the effectiveness of SULFODYNE®, the only extract with authentic, natural, active sulforaphane for the management of premenstrual syndrome.

Study with Vanizem is now published
The in-vivo study on Vanizem is now published. It confirms the potential of the Vanizem (A. melegueta extract) for anxiety reduction, mood improvement, stress mitigation, and sleep enhancement, at doses ranging from 50 to 150 mg, with no reported side effects.

Suylfodyne against viral infection
A preclinical study confirms multi-target mode of action of SULFODYNE® against viral infection.

Boswellin SUPER shows improvements in knee osteoarthritis within five days
Published study : randomized, three-arm, parallel-group, multi-center, placebo-controlled trial with Boswellin SUPER - Boswellia serrata extract. Boswellin SUPER shows improvements in knee osteoarthritis within five days